Related Experiment Video
Updated: Jul 20, 2026

LED-Based In Vitro Screening for Assessing Photoactivable Molecules in Bacterial Photodynamic Inactivation
Published on: January 24, 2025
Transdermal photodynamic therapy--a treatment option for rheumatic destruction of small joints?
Benjamin Funke1, Astrid Jungel, Stanislaw Schastak
1Institute of Pathology, University Hospital Heidelberg, 69121 Heidelberg, Germany. benjamin.funke@med.uni-heidelberg.de
Background And Objective:
Synovectomy of small joints is a therapeutic approach in patients suffering from rheumatoid arthritis (RA). We examined the feasibility of transdermal photodynamic therapy (tPDT) in a fibroblast-induced model of joint destruction using the novel photosensitizer (PS) tetrahydroporphyrin-tetratosylat that shows strong absorption at the near infra-red spectral region.
Materials And Methods:
The functionality of the PDT system was assessed in vitro. Following arthritis induction and PS application, tPDT was applied in vivo. Therapy results were evaluated by measuring joint swelling, serum amyloid A (SAA) and histologically.
Results:
We were able to present a fully functional PDT in vitro. The in vivo therapy modalities were well tolerated by mice. We could demonstrate photodynamic ablation of subcutaneously located tissue (skeletal muscle) without skin damage.
Conclusion:
This study provides the basis for transdermal accessibility of tissue through a photodynamic process which may serve as a minimally invasive synovectomy strategy.
Insights
Transdermal photodynamic therapy (tPDT) shows promise for rheumatoid arthritis treatment. This minimally invasive approach uses a novel photosensitizer to target joint tissue, offering a new synovectomy strategy.
Area of Science:
- Photodynamic Therapy
- Rheumatoid Arthritis Research
- Medical Device Development
Background:
- Rheumatoid arthritis (RA) management often involves synovectomy for small joint destruction.
- Developing minimally invasive therapeutic strategies for RA is crucial.
Purpose of the Study:
- To investigate the feasibility of transdermal photodynamic therapy (tPDT) for joint destruction.
- To evaluate a novel near-infrared absorbing photosensitizer (PS) for tPDT.
Main Methods:
- In vitro assessment of the photodynamic therapy (PDT) system functionality.
- In vivo application of tPDT in a fibroblast-induced arthritis mouse model after PS administration.
- Evaluation of therapeutic outcomes through joint swelling, serum amyloid A (SAA) levels, and histological analysis.
Main Results:
- The PDT system demonstrated full functionality in vitro.
- In vivo tPDT was well-tolerated by the animal subjects.
- Photodynamic ablation of subcutaneous skeletal muscle tissue was achieved without observable skin damage.
Conclusions:
- This study establishes the foundation for transdermal tissue accessibility via photodynamic processes.
- tPDT presents a potential minimally invasive synovectomy strategy for rheumatoid arthritis.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
07:36Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
Related Concept Videos
Transdermal Drug Delivery Systems
Rheumatic Heart Disease III: Medical Management
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Acne Infection
Rheumatic Heart Disease I: Introduction